Experience

Alto Neuroscience Announces $147.9 Million IPO

February 6, 2024

Cooley advised Alto Neuroscience, a company redefining psychiatry by leveraging individuals’ neurobiology to develop personalized and highly effective medicines and helping patients get better faster, on its $147.9 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Christina T. Roupas
Partner in Charge – Chicago, Chicago
Courtney M.W. Tygesson
Partner, Chicago
Laurie Bauer
Partner, Chicago
Nyron J. Persaud
Partner, New York
Kate Hillier
Partner, Seattle
Jon Cousin
Partner, Washington, DC
Elizabeth Anne Wright
Of Counsel, Brussels
Eileen Marshall
Partner, Washington, DC
Geoffrey Spolyar
Partner, Boston
Stephanie Gentile
Partner, New York
Steve Flores
Partner, Chicago
Peter Adams
Partner, San Diego
Phil Mitchell
Partner, New York
Courtney Thorne
Partner, Boston
David Navetta
Partner, Colorado
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Dani Nazemian
Special Counsel, San Diego
Katie Lapidus
Associate, Washington, DC
Trey Reilly
Associate, New York
Adam Bloom
Associate, Chicago
David D. Suh
Associate, Palo Alto
Dionne A. Thomas
Associate, San Diego
Megan E. Bowles
Associate, Chicago
Mor Agam
Associate, New York
Nat Sherrick
Associate, Washington, DC
Edmond Lay
Associate, San Diego
Addison Pierce
Associate, Chicago
Calvin Lee
Associate, New York
Andrew Nelms
Associate, San Francisco
Jason Minio
Paralegal Specialist, Boston
Jeffery Wyzykowski
Patent Agent, Washington, DC

Related Practices & Industries

Cooley Advises Lantheus on Concurrent PIPE Investment, Partnering Transaction, Asset Sale With Perspective Therapeutics

January 9, 2024

Cooley advised Lantheus Holdings, a top publicly traded radiopharmaceutical-focused company, on a concurrent private investment in public equity (PIPE) transaction, partnering transaction and asset sale with Perspective Therapeutics.

Read more

Related contacts

Div Gupta
Partner, New York
Geoffrey Spolyar
Partner, Boston
Bill Roegge
Partner, New York
Ritu Gupta
Special Counsel, New York
Zachary Sonenshine
Associate, New York
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Eileen Marshall
Partner, Washington, DC

Related Practices & Industries

Lexeo Therapeutics Announces $100 Million IPO

November 3, 2023

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Read more

Related contacts

Eric Blanchard
Partner, Boston
Peter Byrne
Partner, New York
Div Gupta
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Xander Lee
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Aaron Pomeroy
Partner, Colorado
Phil Mitchell
Partner, New York
Mark Ballantyne
Partner, Reston
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Stephanie Parker Palmer
Special Counsel, Reston
Joseph Lockinger
Special Counsel, Washington, DC
Christophe Beauduin
Special Counsel, New York
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Dayne Brown
Associate, New York
Ibe Alozie
Associate, Washington, DC
Christopher Nickas
Associate, New York
DeVon Barnett
Associate, Washington, DC
Carly Robinson
Associate, Reston
Calvin Lee
Associate, New York
Jayne M. Munger
Associate, New York
Megan Drill
Associate, San Diego
Erika Freeman
Associate, New York
Mor Agam
Associate, New York
Wyatt Kernell
Associate, New York
Wyatt Kernell
Associate, New York
Alexander Fullman
Associate, New York
Jason Minio
Paralegal Specialist, Boston
Andrew Henderson
Patent Agent, Seattle

Related Practices & Industries

Abivax Announces $235.8 Million IPO

October 20, 2023

Cooley advised Abivax, a clinical-stage biotech company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, on its $235.8 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Ryan Sansom
Partner, Boston
Denny Won
Partner, San Francisco
Aaron Pomeroy
Partner, Colorado
Richard Segal
Partner, New York
Nyron J. Persaud
Partner, New York
Madhuri Roy
Partner, Palo Alto
Courtney Thorne
Partner, Boston
Elizabeth Anne Wright
Of Counsel, Brussels
Xander Lee
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Stephanie Gentile
Partner, New York
Kevin King
Partner, Washington, DC
Katie Kazem
Partner, Reston
Natasha Leskovsek
Of Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Minkyu Park
Associate, New York
Jesse Schulman
Associate, Washington, DC
Barry Kuang
Associate, Boston
Olivia Creser
Associate, New York
Peter A. Haddad
Associate, San Diego
Samuel Paullin
Associate, Chicago
Evan Leitner
Associate, New York
Rick Jantz
Associate, Los Angeles Santa Monica
Cara Buchicchio
Associate, New York
Jason Valentine
Associate, Washington, DC
Jessica Koffel
Associate, Brussels
Mor Agam
Associate, New York
Cathy Rude
Paralegal Specialist, Boston

Related Practices & Industries

Merus – $172.5 Million Follow-on Offering

August 14, 2023

Cooley advised the underwriters in Merus’ $172.5 million follow-on offering. Jefferies, BofA Securities, Guggenheim Securities and William Blair acted as joint book-running managers for the offering. Merus is a clinical-stage oncology company developing innovative, full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics. Partners Denny Won, Courtney Thorne and Div Gupta led the Cooley team.

Related contacts

Denny Won
Partner, San Francisco
Courtney Thorne
Partner, Boston
Div Gupta
Partner, New York
Evan Leitner
Associate, New York
David D. Kim
Associate, San Francisco
Charles York
Associate, New York
Peter A. Haddad
Associate, San Diego

Related Practices & Industries

View more

Admissions & credentials

California

New York

Texas

Rankings & accolades

Chambers USA: Life Sciences: Corporate/Commercial – Nationwide (2022 – 2023)

Chambers USA: Capital Markets: Debt & Equity: Eastern United States – Nationwide (2020 – 2023)

Legal 500: Key Lawyer - Capital Markets: Equity Offerings and Healthcare: Life Sciences (2020 – 2021)

Law 360 Rising Star (2015)

Who's Who Legal: Life Sciences (2018)

highly regarded for his experience assisting life sciences companies on IPOs and other capital markets matters

Divakar is excellent in supporting our company.

Chambers USA: Life Sciences: Corporate/Commercial 

Nationwide (2022)